Canopy Growth Corp (CGC)

Insider Trading Filed: 2026-04-02

The reporting person, David Angelo Lazzarato, sold 15,624 common shares of Canopy Growth Corp at a price of $0.93 per share on March 31, 2026.
The sale of shares appears to be related to tax obligations associated with the vesting of restricted stock units (RSUs) granted to the reporting person on June 3, 2025.
Following the reported transaction, the reporting person still holds 72,048 common shares of Canopy Growth Corp.

Insider Trading Filed: 2026-04-02

Insider Joseph Bayern sold 2,658 shares of Canopy Growth Corp (CGC) on March 31, 2026 at $0.93 per share, reducing his direct ownership to 40,000 shares.
The share sale appears to be related to tax obligations associated with the vesting of restricted stock units (RSUs) previously granted to Bayern.
Insider transactions can provide insights into management's views on the company's prospects, though the sale here seems routine and not an indicator of broader concerns.

Insider Trading Filed: 2026-04-02

Insider M. Shan Atkins, a director of Canopy Growth Corp, sold 2,074 common shares on March 31, 2026 at $0.93 per share, reducing their direct ownership to 41,390 shares.
The share sale appears to be related to tax obligations associated with the vesting of restricted stock units granted to the insider in August 2025.
The relatively small size of the insider sale, representing less than 5% of their total holdings, suggests this transaction may not be a significant indicator of the insider's outlook on the company.

Insider Trading Filed: 2026-04-02

Theresa Yanofsky, a director at Canopy Growth Corp, sold 10,373 common shares at $0.93 per share on March 31, 2026.
The sale of shares was likely to cover tax obligations associated with the vesting of restricted stock units granted to Yanofsky on June 3, 2025.
With 53,145 shares remaining, Yanofsky's ownership in the company has decreased, potentially signaling a less bullish outlook on the stock.

Current Report Filed: 2026-03-16

Canopy Growth has completed the acquisition of MTL Cannabis Corp, a strategic move that expands the company's market presence and product portfolio.
The issuance of additional Canopy Growth shares to the former shareholders of Montreal Cannabis Medical, Inc. suggests the company is consolidating its operations and addressing past obligations.
The transaction was finalized through a plan of arrangement, indicating a structured and legally compliant process was followed.

Quarterly Report Filed: 2026-02-06

Canopy Growth Corp reported a decline in revenue across its Canadian cannabis and international markets segments during the quarter, indicating ongoing challenges in the competitive cannabis industry.
The company continued to invest in its operations, including its intellectual property and production and warehouse equipment, while also recording impairment charges related to its Elevate loan receivable and Canopy USA LLC equity method investment.
Canopy Growth Corp raised additional capital through various at-the-market equity programs and debt exchanges, but also reported higher selling, general, and administrative expenses, which could pressure profitability.

Current Report Filed: 2026-02-06

Canopy Growth reported its fiscal third quarter 2025 results, indicating the company's financial performance during the period.
The press release announcement provides details on the company's latest quarterly financial results, which investors will likely analyze to gauge Canopy Growth's overall business trends and outlook.
Investors should review the full press release for additional context on Canopy Growth's operations, financial metrics, and any material updates or changes that could impact the company's future performance.

Current Report Filed: 2026-01-08

Canopy Growth secured a $162.1 million senior secured loan with a 5-year term, which it will use to repay existing debt and fund working capital and acquisitions.
Canopy issued 18.7 million common share purchase warrants to the lenders, with each warrant exercisable at $1.30 per share for 5 years.
Canopy exchanged $96.4 million of its existing convertible debentures for new $55 million convertible debentures maturing in 2031, along with 12.7 million warrants and 9.5 million common shares.

Insider Trading Filed: 2026-01-02

Insider David Angelo Lazzarato, a director at Canopy Growth Corp, has sold 15,715 common shares at a price of $1.13 per share.
The share sale is likely related to tax obligations associated with the vesting of 15,715 restricted stock units (RSUs) granted to Lazzarato on June 3, 2025.
Lazzarato's remaining beneficial ownership of 87,672 common shares indicates he still holds a significant position in the company.

Insider Trading Filed: 2026-01-02

Theresa Yanofsky, a director at Canopy Growth Corp, has sold 10,434 common shares on December 31, 2025 at $1.13 per share, reducing her direct ownership to 63,518 shares.
The sale of shares appears to be related to tax obligations associated with the vesting of restricted stock units (RSUs) granted to Yanofsky earlier in 2025.
Insider selling activity, especially by directors, can be a signal of sentiment towards the company's prospects and should be monitored by investors.

Important Information